Skip to main content
Log in

Okuläre Graft-Versus-Host Erkrankung

Leitlinie der Deutschen Ophthalmologischen Gesellschaft (DOG) und des Berufsverbands der Augenärzte Deutschlands e. V. (BVA)

Ocular Graft-Versus-Host Disease

Guidelines of the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)

  • Leitlinien, Stellungnahmen und Empfehlungen
  • Published:
Die Ophthalmologie Aims and scope Submit manuscript

Zusammenfassung

Leitlinien sind Orientierungshilfen im Sinne von „Handlungs- und Entscheidungskorridoren“, von denen in begründeten Fällen abgewichen werden kann oder sogar muss. Sie beschreiben, was Augenärzte für eine angemessene Patientenversorgung in der Praxis für geboten halten. Dies entspricht in vielen Fällen nicht dem Leistungsniveau der gesetzlichen Krankenversicherung in Deutschland (s. Präambel).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Newman RG et al (2013) The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success. Immunol Res 57(1):125–139

    Article  CAS  Google Scholar 

  2. Inamoto Y et al (2019) Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the late effects and quality of life working committee of the CIBMTR and transplant complications working party of the EBMT. Bone Marrow Transplant 54(5):648–661

    Article  Google Scholar 

  3. Dietrich-Ntoukas T et al (2012) Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss consensus conference on clinical practice in chronic GVHD. Cornea 31(3):299–310

    Article  Google Scholar 

  4. Filipovich AH et al (2005) National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11(12):945–956

    Article  Google Scholar 

  5. Na KS et al (2015) Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 50(11):1459–1464

    Article  CAS  Google Scholar 

  6. Westekemper H et al (2017) Ocular graft versus host disease : corneal complications. Ophthalmologe 114(8):697–702

    Article  CAS  Google Scholar 

  7. Giannaccare G et al (2019) Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle. Graefes Arch Clin Exp Ophthalmol 257(7):1341–1351

    Article  Google Scholar 

  8. Hu B, Qiu Y, Hong J (2020) Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD). Ocul Surf 18(2):298–304

    Article  Google Scholar 

  9. Engel LA et al (2015) Meibography and meibomian gland measurements in ocular graft-versus-host disease. Bone Marrow Transplant 50(7):961–967. https://doi.org/10.1038/bmt.2015.72

    Article  CAS  Google Scholar 

  10. Mirza N et al (2016) Graft versus self (GvS) against T‑cell autoantigens is a mechanism of graft-host interaction. Proc Natl Acad Sci U S A 113(48):13827–13832

    Article  CAS  Google Scholar 

  11. Mohty M et al (2002) Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. Blood 100(9):3128–3134

    Article  CAS  Google Scholar 

  12. Steven P et al (2015) Semifluorinated alkane eye drops for treatment of dry eye disease—a prospective, multicenter noninterventional study. J Ocul Pharmacol Ther 31(8):498–503

    Article  CAS  Google Scholar 

  13. Hessen M, Akpek EK (2012) Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol 12(5):540–547

    Article  CAS  Google Scholar 

  14. Inamoto Y et al (2019) Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the late effects and quality of life working committee of the CIBMTR and transplant complications working party of the EBMT. Bone Marrow Transplant 54(5):662–673

    Article  Google Scholar 

  15. Steven P et al (2020) Adverse environmental conditions are a risk factor for ocular GvHD after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 55(9):1851–1853. https://doi.org/10.1038/s41409-020-0824-6

    Article  CAS  Google Scholar 

  16. Espana EM et al (2013) Graft versus host disease: clinical evaluation, diagnosis and management. Graefes Arch Clin Exp Ophthalmol 251(5):1257–1266

    Article  Google Scholar 

  17. Jabs DA et al (1989) The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol 107(9):1343–1348

    Article  CAS  Google Scholar 

  18. Jagasia MH et al (2015) National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant 21(3):389–401.e1

    Article  Google Scholar 

  19. Giannaccare G et al (2019) In vivo confocal microscopy morphometric analysis of corneal subbasal nerve plexus in dry eye disease using newly developed fully automated system. Graefes Arch Clin Exp Ophthalmol 257(3):583–589

    Article  CAS  Google Scholar 

  20. Versura P et al (2013) Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye. Cornea 32(4):412–418

    Article  Google Scholar 

  21. Berchicci L et al (2014) Tear osmolarity in ocular graft-versus-host disease. Cornea 33(12):1252–1256

    Article  Google Scholar 

  22. Schargus M et al (2015) Correlation between tear film osmolarity and the disease score of the international chronic ocular graft-versus-host-disease consensus group in hematopoietic stem cell transplantation patients. Cornea 34(8):911–916

    Article  Google Scholar 

  23. Ban Y et al (2011) Morphologic evaluation of meibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy. Mol Vis 17:2533

    Google Scholar 

  24. He J et al (2017) In vivo confocal microscopy evaluation of ocular surface with graft-versus-host disease-related dry eye disease. Sci Rep 7(1):10720

    Article  Google Scholar 

  25. Steger B et al (2015) In vivo confocal microscopic characterisation of the cornea in chronic graft-versus-host disease related severe dry eye disease. Br J Ophthalmol 99(2):160–165

    Article  CAS  Google Scholar 

  26. Giannaccare G et al (2019) Corneal biomechanical alterations in patients with chronic ocular graft versus-host disease. PLoS One 14(4):e213117

    Article  CAS  Google Scholar 

  27. Abud TB et al (2016) A clinical trial comparing the safety and efficacy of topical tacrolimus versus methylprednisolone in ocular graft-versus-host disease. Ophthalmology 123(7):1449–1457

    Article  Google Scholar 

  28. Dastjerdi MH, Hamrah P, Dana R (2009) High-frequency topical cyclosporine 0.05 % in the treatment of severe dry eye refractory to twice-daily regimen. Cornea 28(10):1091–1096

    Article  Google Scholar 

  29. Wan KH, Chen LJ, Young AL (2015) Efficacy and safety of topical 0.05 % cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis. Ocul Surf 13(3):213–225

    Article  Google Scholar 

  30. Dignan FL et al (2012) Organ-specific management and supportive care in chronic graft-versus-host disease. Br J Haematol 158(1):62–78

    Article  CAS  Google Scholar 

  31. Ervin AM, Law A, Pucker AD (2019) Punctal occlusion for dry eye syndrome: summary of a Cochrane systematic review. Br J Ophthalmol 103(3):301–306

    Article  Google Scholar 

  32. Sabti S et al (2012) Punctal occlusion is safe and efficient for the treatment of keratoconjunctivitis sicca in patients with ocular GvHD. Bone Marrow Transplant 47(7):981–984

    Article  CAS  Google Scholar 

  33. Jacobs DS, Rosenthal P (2007) Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease. Cornea 26(10):1195–1199

    Article  Google Scholar 

  34. Stoyanova EI et al (2015) Bandage and scleral contact lenses for ocular graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. Acta Ophthalmol 93(7):e604. https://doi.org/10.1111/aos.12711

    Article  Google Scholar 

  35. Ogawa Y et al (2003) Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 31(7):579–583

    Article  CAS  Google Scholar 

  36. Tahmaz V et al (2017) Treatment of severe chronic ocular graft-versus-host disease using 100 % autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study. Br J Ophthalmol 101(3):322–326

    Google Scholar 

  37. Inagaki E et al (2011) Four cases of corneal perforation in patients with chronic graft-versus-host disease. Mol Vis 17:598–606

    Google Scholar 

  38. Yeh PT et al (2006) Recurrent corneal perforation and acute calcareous corneal degeneration in chronic graft-versus-host disease. J Formos Med Assoc 105(4):334–339

    Article  Google Scholar 

  39. Peris-Martinez C et al (2001) Multilayer amniotic membrane transplantation in severe ocular graft versus host disease. Eur J Ophthalmol 11(2):183–186

    Article  CAS  Google Scholar 

  40. Shah A, Santhiago MR, Espana EM (2016) Cataract surgery in patients with chronic severe graft-versus-host disease. J Cataract Refract Surg 42(6):833–839

    Article  Google Scholar 

  41. Claessens D, Schuster AK (2019) Correlation of Quantitative Metamorphopsia Measurement and Central Retinal Thickness in Diabetic Macular Edema and Age-Related Exsudative Macular Degeneration. Klin Monbl Augenheilkd 236(7):877–884. https://doi.org/10.1055/s-0043-125080. Epub 2018 Feb 28

    Article  Google Scholar 

Download references

Redaktionskomitee

Bertram, Bernd; Claessens, Daniela; Cursiefen, Claus; Dietrich-Ntoukas, Tina; Eberwein, Philipp; Ostrowski, Angelika; Seitz, Berthold; Steven, Philipp; Uhlig, Constantin; Westekemper, Henrike

Author information

Authors and Affiliations

Consortia

Ethics declarations

Interessenkonflikt

Siehe Tab. 4 im Anhang.

Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

The supplement containing this article is not sponsored by industry.

Additional information

Das Redaktionskomitee dieser Stellungnahme wird am Beitragsende gelistet.

AWMF-Register-Nr. 045-017

Versions-Nummer: 1.1

Erstveröffentlichung: 06/2020

Nächste Überprüfung geplant: 06/2025

Hier aufgeführte, im Leitlinienreport bzw. den Evidenztabellen jedoch nicht enthaltene Publikationen sind expertenbeigesteuert (s. Leitlinienreport).

figure qr

QR-Code scannen & Beitrag online lesen

Anhang

Anhang

Tabelle zur Erklärung von Interessen und Umgang mit Interessenkonflikten

Im Folgenden sind die Interessenerklärungen als tabellarische Zusammenfassung dargestellt sowie die Ergebnisse der Interessenkonfliktbewertung und Maßnahmen, die nach Diskussion der Sachverhalte von der der LL-Gruppe beschlossen und im Rahmen der Konsensuskonferenz umgesetzt wurden (Tab. 4).

Tab. 4 Erklärung von Interessen und Umgang mit Interessenkonflikten – Leitlinienkoordination: Bertram, Bernd; Leitlinie: Okuläre Graft-versus-Host-Erkrankung; Registernummer: 045-017

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deutsche Ophthalmologische Gesellschaft (DOG)., Berufsverband der Augenärzte Deutschlands e. V. (BVA). Okuläre Graft-Versus-Host Erkrankung. Ophthalmologie 120 (Suppl 1), 50–58 (2023). https://doi.org/10.1007/s00347-022-01781-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-022-01781-6

Schlüsselwörter

Navigation